The U.S. has ordered 600,000 doses of a new treatment that helps the immune system combat the coronavirus’ omicron variant.
Subscribe to:
Post Comments (Atom)
< + > EVERSANA Merges with Waltz Health to Create a New Force in Pharma Commercialization and Prescription Drug Access
Combined Company Offers Next-Generation Commercialization Model that Directly Connects Life Sciences to Payers and Patients to Accelerate Ac...
-
Welcome to the weekly edition of Healthcare IT Today Bonus Features . This article will be a weekly roundup of interesting stories, product ...
-
Training artificial intelligence models on more diverse image and data sets can augment decision making, overcome knowledge gaps, and promot...
-
As I’m sure you know, times are tough. Wages have largely remained the same while prices have risen across the board – and healthcare is no ...
No comments:
Post a Comment